NCT06563635已完成不适用
Frequency of Tuberculosis in Psoriasis Patients Using Anti-TNF Therapy During 15 Years of Follow-up.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 719
- 试验地点
- 1
- 主要终点
- tuberculosis rate
研究概览
简要总结
Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center.
详细描述
Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center. TNF inhibitor therapy may increase the risk for tuberculosis infection. According to medical data in our hospital in last 15 years, tuberculosis rate of psoriasis patients receiving etanercept, adalimumab and infliximab will be compared.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 100 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •psoriasis patients receiving TNF inhibitor therapy
排除标准
- •patients without TNF inhibitor therapy
结局指标
主要结局
tuberculosis rate
时间窗: patients from June 2007 to January 2023, up to 15 years
number of patients with tuberculosis infection after receiving TNF inhibitor therapy
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus InfectionPsoriasisInflammatory Bowel DiseasesNCT02376478Medical University of Vienna222
已完成
4 期
Response to Ustekinumab for Anti-tnf Induced Psoriasiform Skin LesionsInflammatory Bowel DiseasesPsoriasisNCT03629379Universitaire Ziekenhuizen KU Leuven20
已完成
不适用
Study of TNF-Antagonism in Metabolic SyndromeMetabolic SyndromeNCT00409318Massachusetts General Hospital56
已完成
不适用
Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF TherapyTuberculosisNCT00811343Assistance Publique - Hôpitaux de Paris430
Unknown
不适用
Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment ResponseTuberculosis, PulmonaryNCT03416309University of Turin, Italy257